Clinical trial
Scintigraphic Assessment of I- Transport in Metastatic Breast Cancer and…
NCT00185809 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00185809 |
|---|---|
| Title | Scintigraphic Assessment of I- Transport in Metastatic Breast Cancer and Evaluation of I31I Ablative Therapy: (Part I) Radioiodide Imaging Study |
| Official title | Scintigraphic Assessment of I- Transport in Metastatic Breast Cancer and Evaluation of I31I Ablative Therapy: (Part I) Radioiodide Imaging Study |
| Lead sponsor | Stanford University, Other |
| Collaborators | Susan G. Komen Breast Cancer Foundation |
| Status | Completed |
| Study type | Observational |
| Conditions | Breast Cancer |
| Enrollment | 25 |
| Start date | Nov 1, 2000 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Sep 16, 2005 |
| Last update posted | Jul 20, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: